Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker
From MaRDI portal
Publication:5222223
DOI10.1093/BIOMET/ASZ065zbMath1435.62402OpenAlexW2997938744WikidataQ96686105 ScholiaQ96686105MaRDI QIDQ5222223
Tianxi Cai, L. Tian, Layla Parast, Xu An Wang
Publication date: 1 April 2020
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc7315285
nonparametric estimationrandomized clinical trialsurrogate markerproportion of treatment effect explained
Density estimation (62G07) Applications of statistics to biology and medical sciences; meta analysis (62P10) Sampling theory, sample surveys (62D05)
Related Items (4)
Evaluating multiple surrogate markers with censored data ⋮ Quantifying direct and indirect effect for longitudinal mediator and survival outcome using joint modeling approach ⋮ Robust Approach to Combining Multiple Markers to Improve Surrogacy ⋮ Testing for Heterogeneity in the Utility of a Surrogate Marker
This page was built for publication: Model-free approach to quantifying the proportion of treatment effect explained by a surrogate marker